Shares of XenoPort, Inc. XNPT are lower on the session by 10.94%, trading at $5.94.
Overall call volume is now running at 2.52x the daily average, with 36% of all calls traded being purchases on the offer. 3,824 contracts have traded on the session so far.
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally discovered product candidates, which utilizes the body's natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in